Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Diabetes

  Free Subscription


Articles published in Acta Ophthalmol

Retrieve available abstracts of 85 articles:
HTML format



Single Articles


    May 2020
  1. VERGMANN AS, Grauslund J
    Changes of visual fields in treatment of proliferative diabetic retinopathy: a systematic review.
    Acta Ophthalmol. 2020 May 18. doi: 10.1111/aos.14474.
    PubMed     Abstract available


  2. C B B VEIBY N, Simeunovic A, Heier M, Brunborg C, et al
    Venular oxygen saturation is increased in young patients with type 1 diabetes and mild nonproliferative diabetic retinopathy.
    Acta Ophthalmol. 2020 May 15. doi: 10.1111/aos.14462.
    PubMed     Abstract available


    April 2020
  3. MATHIS T, Mendes M, Dot C, Bouteleux V, et al
    Increased choroidal thickness: a new indicator for monitoring diabetic macular oedema recurrence.
    Acta Ophthalmol. 2020 Apr 17. doi: 10.1111/aos.14447.
    PubMed     Abstract available


  4. GABRIELLE PH, Massin P, Arnould L, Couturier A, et al
    Development of a 1-year risk-prediction nomogram for good functional response with anti-VEGF agents in naive diabetic macular oedema.
    Acta Ophthalmol. 2020 Apr 8. doi: 10.1111/aos.14428.
    PubMed     Abstract available


  5. KIM M, Kim RY, Park W, Park YG, et al
    Electroretinography and retinal microvascular changes in type 2 diabetes.
    Acta Ophthalmol. 2020 Apr 4. doi: 10.1111/aos.14421.
    PubMed     Abstract available


    March 2020
  6. ESTIL S, Steinarsson AThorn, Einarsson S, Aspelund T, et al
    Diabetic eye screening with variable screening intervals based on individual risk factors is safe and effective in ophthalmic practice.
    Acta Ophthalmol. 2020 Mar 25. doi: 10.1111/aos.14425.
    PubMed     Abstract available


  7. BUSCH C, Okada M, Zur D, Fraser-Bell S, et al
    Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuity.
    Acta Ophthalmol. 2020 Mar 1. doi: 10.1111/aos.14390.
    PubMed     Abstract available


    February 2020
  8. YAO TT, Yang Y, Jin XL, Wang YX, et al
    Intraocular pharmacokinetics of anti-vascular endothelial growth factor agents by intraoperative subretinal versus intravitreal injection in silicone oil-filled eyes of proliferative diabetic retinopathy: a randomized controlled pilot study.
    Acta Ophthalmol. 2020 Feb 29. doi: 10.1111/aos.14386.
    PubMed     Abstract available


  9. ELKJAER AS, Lynge SK, Grauslund J
    Evidence and indications for systemic treatment in diabetic retinopathy: a systematic review.
    Acta Ophthalmol. 2020 Feb 26. doi: 10.1111/aos.14377.
    PubMed     Abstract available


  10. DE CLERCK EEB, Schouten JSAG, Berendschot TTJM, Koolschijn RS, et al
    Reduced corneal nerve fibre length in prediabetes and type 2 diabetes: The Maastricht Study.
    Acta Ophthalmol. 2020 Feb 3. doi: 10.1111/aos.14359.
    PubMed     Abstract available


    January 2020
  11. BA-ALI S, Brondsted AE, Andersen HU, Jennum P, et al
    Pupillary light responses in type 1 and type 2 diabetics with and without retinopathy.
    Acta Ophthalmol. 2020 Jan 13. doi: 10.1111/aos.14348.
    PubMed     Abstract available


  12. SEVER O, Horozoglu F
    Bariatric surgery might aggravate proliferative diabetic retinopathy.
    Acta Ophthalmol. 2020 Jan 7. doi: 10.1111/aos.14342.
    PubMed     Abstract available


    December 2019
  13. EPSTEIN D, Mirabelli P, Lovestam Adrian M
    Treatment algorithm with dexamethasone intravitreal implant in patients with diabetic macular edema.
    Acta Ophthalmol. 2019 Dec 29. doi: 10.1111/aos.14339.
    PubMed    


  14. LANG GE, Stahl A, Voegeler J, Quiering C, et al
    Efficacy and safety of ranibizumab with or without panretinal laser photocoagulation versus laser photocoagulation alone in proliferative diabetic retinopathy - the PRIDE study.
    Acta Ophthalmol. 2019 Dec 6. doi: 10.1111/aos.14312.
    PubMed     Abstract available


    November 2019
  15. GONZALEZ-GONZALO C, Sanchez-Gutierrez V, Hernandez-Martinez P, Contreras I, et al
    Evaluation of a deep learning system for the joint automated detection of diabetic retinopathy and age-related macular degeneration.
    Acta Ophthalmol. 2019 Nov 26. doi: 10.1111/aos.14306.
    PubMed     Abstract available


  16. BRITO P, Costa J, Gomes N, Costa S, et al
    Serum pro-inflammatory factors as predictors of persistent diabetic macular oedema with limited anatomic response to anti-VEGF: association with intravitreal injection treatment profiles in real-world setting.
    Acta Ophthalmol. 2019 Nov 19. doi: 10.1111/aos.14308.
    PubMed     Abstract available


  17. PODKOWINSKI D, Orlowski-Wimmer E, Zlabinger G, Pollreisz A, et al
    Aqueous humour cytokine changes during a loading phase of intravitreal ranibizumab or dexamethasone implant in diabetic macular oedema.
    Acta Ophthalmol. 2019 Nov 17. doi: 10.1111/aos.14297.
    PubMed     Abstract available


  18. BOLZ M, Podkowinski D, Pretzl J, Mursch-Edlmayr AS, et al
    Patterns of morphologic alteration correlate with vision in diabetic macular oedema: a cross-sectional evaluation of patients using the SAVE II protocol.
    Acta Ophthalmol. 2019 Nov 17. doi: 10.1111/aos.14288.
    PubMed     Abstract available


  19. TAKAYAMA K, Someya H, Yokoyama H, Kimura T, et al
    Prognostic factors of revitrectomy for complications in eyes with proliferative diabetic retinopathy: a retrospective multicentre study.
    Acta Ophthalmol. 2019 Nov 1. doi: 10.1111/aos.14292.
    PubMed     Abstract available


  20. PETRARCA R, Soare C, Wong R, Desai R, et al
    Intravitreal ranibizumab for persistent diabetic vitreous haemorrhage: a randomised, double-masked, placebo-controlled feasibility study.
    Acta Ophthalmol. 2019 Nov 1. doi: 10.1111/aos.14282.
    PubMed     Abstract available


    October 2019
  21. TIAN M, Wolf S, Munk MR, Schaal KB, et al
    Evaluation of different Swept'Source optical coherence tomography angiography (SS-OCTA) slabs for the detection of features of diabetic retinopathy.
    Acta Ophthalmol. 2019 Oct 30. doi: 10.1111/aos.14299.
    PubMed     Abstract available


  22. GRANSTAM E, Rosenblad A, Modher Raghib A, Granstrom T, et al
    Long-term follow-up of antivascular endothelial growth factor treatment for diabetic macular oedema: a four-year real-world study.
    Acta Ophthalmol. 2019 Oct 27. doi: 10.1111/aos.14290.
    PubMed     Abstract available


  23. BLINDBAEK SL, Peto T, Grauslund J
    Alterations in retinal arteriolar microvascular structure associate with higher treatment burden in patients with diabetic macular oedema: results from a 12-month prospective clinical trial.
    Acta Ophthalmol. 2019 Oct 25. doi: 10.1111/aos.14278.
    PubMed     Abstract available


  24. GERENDAS BS, Hatz K, Kaider A, Zulewski H, et al
    Ganglion cell layer thickening in well-controlled patients with type 1 diabetes: an early sign for diabetic retinopathy?
    Acta Ophthalmol. 2019 Oct 25. doi: 10.1111/aos.14273.
    PubMed     Abstract available


  25. MITSCH C, Pemp B, Pollreisz A, Gleiss A, et al
    Short-time effect of intravitreal injections on retinal vascular oxygenation and vessel diameter in patients with diabetic macular oedema or neovascular age-related macular degeneration.
    Acta Ophthalmol. 2019 Oct 25. doi: 10.1111/aos.14276.
    PubMed     Abstract available


  26. BLINDBAEK SL, Peto T, Grauslund J
    Aflibercept and navigated versus conventional laser in diabetic macular oedema: a 12-month randomized clinical trial.
    Acta Ophthalmol. 2019 Oct 10. doi: 10.1111/aos.14266.
    PubMed     Abstract available


    September 2019
  27. MCANANY JJ, Park JC, Liu K, Liu M, et al
    Contrast sensitivity is associated with outer-retina thickness in early-stage diabetic retinopathy.
    Acta Ophthalmol. 2019 Sep 13. doi: 10.1111/aos.14241.
    PubMed     Abstract available


  28. VERBRAAK FD, Schmidt-Erfurth U, Grzybowski A, Abramoff M, et al
    Is automated screening for diabetic retinopathy indeed not yet ready as stated by Grauslund et al.?
    Acta Ophthalmol. 2019 Sep 1. doi: 10.1111/aos.14236.
    PubMed    


    August 2019
  29. MUNUERA-GIFRE E, Saez M, Juvinya-Canals D, Rodriguez-Poncelas A, et al
    Analysis of the location of retinal lesions in central retinographies of patients with Type 2 diabetes.
    Acta Ophthalmol. 2019 Aug 30. doi: 10.1111/aos.14223.
    PubMed     Abstract available


  30. ZUR D, Iglicki M, Sala-Puigdollers A, Chhablani J, et al
    Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implant.
    Acta Ophthalmol. 2019 Aug 17. doi: 10.1111/aos.14230.
    PubMed     Abstract available


  31. SHEN Y, Cao H, Chen F, Suo Y, et al
    A cross-sectional study of vitreous and serum high mobility group box-1 levels in proliferative diabetic retinopathy.
    Acta Ophthalmol. 2019 Aug 17. doi: 10.1111/aos.14228.
    PubMed     Abstract available


  32. LI T, Jia Y, Wang S, Xu Y, et al
    Change in peripapillary and macular choroidal thickness change in children with type 1 diabetes mellitus without visual impairment or diabetic retinopathy.
    Acta Ophthalmol. 2019 Aug 17. doi: 10.1111/aos.14225.
    PubMed     Abstract available


    July 2019
  33. ABU EL-ASRAR AM, Ahmad A, Allegaert E, Siddiquei MM, et al
    Galectin-1 studies in proliferative diabetic retinopathy.
    Acta Ophthalmol. 2019 Jul 18. doi: 10.1111/aos.14191.
    PubMed     Abstract available


  34. NGHIEM AZ, Nderitu P, Lukic M, Khatun M, et al
    Comparing diabetic retinopathy lesions in scanning laser ophthalmoscopy and colour fundus photography.
    Acta Ophthalmol. 2019 Jul 8. doi: 10.1111/aos.14106.
    PubMed     Abstract available


    June 2019
  35. KARST SG, Schuster M, Mitsch C, Meyer EL, et al
    Atrophy of the central neuroretina in patients treated for diabetic macular edema.
    Acta Ophthalmol. 2019 Jun 22. doi: 10.1111/aos.14173.
    PubMed     Abstract available


  36. NISHIDA K, Miura K, Sakaguchi H, Kamei M, et al
    The impact of spot size, spacing, pattern, duration and intensity of burns on the photocoagulation index in a geometric simulation of pan-retinal laser photocoagulation.
    Acta Ophthalmol. 2019;97:e551-e558.
    PubMed     Abstract available


    May 2019
  37. TAKASAGO Y, Fujita T, Nakano Y, Osaka R, et al
    Ranibizumab treatment improves diabetic macular oedema without influencing retinal oximetry parameters.
    Acta Ophthalmol. 2019 May 24. doi: 10.1111/aos.14145.
    PubMed     Abstract available


  38. CEKLIC L, Huf W, Ebneter A, Wolf S, et al
    The impact of ganglion cell layer cysts in diabetic macular oedema treated with anti-vascular endothelial growth factor.
    Acta Ophthalmol. 2019 May 17. doi: 10.1111/aos.14137.
    PubMed     Abstract available


  39. GRZYBOWSKI A, Brona P
    A pilot study of autonomous artificial intelligence-based diabetic retinopathy screening in Poland.
    Acta Ophthalmol. 2019 May 3. doi: 10.1111/aos.14132.
    PubMed    


    April 2019
  40. BYBERG S, Vistisen D, Diaz L, Charles MH, et al
    Optos wide-field imaging versus conventional camera imaging in Danish patients with type 2 diabetes.
    Acta Ophthalmol. 2019 Apr 15. doi: 10.1111/aos.14118.
    PubMed     Abstract available


  41. OMARI A, Niziol LM, Gardner TW
    Reading deficits in diabetic patients treated with panretinal photocoagulation and good visual acuity.
    Acta Ophthalmol. 2019 Apr 9. doi: 10.1111/aos.14097.
    PubMed     Abstract available


    March 2019
  42. SUN Z, Liu X, Bian C, Wu S, et al
    Sub-Tenon depository triamcinolone and glycaemic management in diabetic patients.
    Acta Ophthalmol. 2019 Mar 22. doi: 10.1111/aos.14100.
    PubMed    


  43. WANG J, Gao X, Liu J, Wang J, et al
    Effect of intravitreal conbercept treatment on the expression of Long Noncoding RNAs and mRNAs in Proliferative Diabetic Retinopathy Patients.
    Acta Ophthalmol. 2019 Mar 22. doi: 10.1111/aos.14083.
    PubMed     Abstract available


    February 2019
  44. LI L, Almansoob S, Zhang P, Zhou YD, et al
    Quantitative analysis of retinal and choroid capillary ischaemia using optical coherence tomography angiography in type 2 diabetes.
    Acta Ophthalmol. 2019 Feb 27. doi: 10.1111/aos.14076.
    PubMed     Abstract available


  45. COMET A, Gascon P, Sauvan L, Donnadieu B, et al
    INVICTUS: intravitreal anti-VEGF and dexamethasone implant comparison for the treatment of diabetic macular edema: a 6 months follow-up Study.
    Acta Ophthalmol. 2019 Feb 11. doi: 10.1111/aos.14057.
    PubMed    


    January 2019
  46. TAYYARI F, Khuu LA, Sivak JM, Flanagan JG, et al
    Retinal blood oxygen saturation and aqueous humour biomarkers in early diabetic retinopathy.
    Acta Ophthalmol. 2019 Jan 28. doi: 10.1111/aos.14016.
    PubMed     Abstract available


  47. KAIZU Y, Nakao S, Arima M, Wada I, et al
    Capillary dropout is dominant in deep capillary plexus in early diabetic retinopathy in optical coherence tomography angiography.
    Acta Ophthalmol. 2019 Jan 28. doi: 10.1111/aos.14041.
    PubMed    


  48. MOREN A, Sundbom M, Ottosson J, Granstam E, et al
    Response: Debate continues. Gastric bypass surgery does not increase the risk for sight-threatening diabetic retinopathy.
    Acta Ophthalmol. 2019 Jan 11. doi: 10.1111/aos.14022.
    PubMed    


  49. DANNI R, Viljanen A, Aaronson A, Tuuminen R, et al
    Preoperative anti-inflammatory treatment of diabetic patients does not improve recovery from cataract surgery when postoperatively treated with a combination of prednisolone acetate and nepafenac.
    Acta Ophthalmol. 2019 Jan 8. doi: 10.1111/aos.14018.
    PubMed     Abstract available


    December 2018
  50. BLINDBAEK SL, Peto T, Grauslund J
    How do we evaluate the role of focal/grid photocoagulation in the treatment of diabetic macular edema?
    Acta Ophthalmol. 2018 Dec 21. doi: 10.1111/aos.13997.
    PubMed     Abstract available


  51. GABRIELLE PH, Massin P, Kodjikian L, Erginay A, et al
    Central retinal thickness following panretinal photocoagulation using a multispot semi-automated pattern-scanning laser to treat ischaemic diabetic retinopathy: Treatment in one session compared with four monthly sessions.
    Acta Ophthalmol. 2018 Dec 18. doi: 10.1111/aos.14002.
    PubMed     Abstract available


  52. SEVER O
    Debate continues: Gastric bypass surgery does not increase the risk for sight-threatening diabetic retinopathy.
    Acta Ophthalmol. 2018 Dec 3. doi: 10.1111/aos.13990.
    PubMed    


    November 2018
  53. SAHIN M, Sahin A, Turkcu FM
    The relationship between retinal thickness and neurodegeneration in early diabetic patients.
    Acta Ophthalmol. 2018 Nov 18. doi: 10.1111/aos.13977.
    PubMed    


  54. DIETZEL A, Schanner C, Falck A, Hautala N, et al
    Automatic detection of diabetic retinopathy and its progression in sequential fundus images of patients with diabetes.
    Acta Ophthalmol. 2018 Nov 18. doi: 10.1111/aos.13976.
    PubMed    


    October 2018
  55. HIGHAM AK, Tahir MI, Gala K, Verroiopoulos G, et al
    Are the real-life outcomes of using aflibercept in diabetic macular oedema comparable to the landmark studies?
    Acta Ophthalmol. 2018 Oct 27. doi: 10.1111/aos.13945.
    PubMed    


  56. BONFIGLIO V, Reibaldi M, Pizzo A, Russo A, et al
    Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.
    Acta Ophthalmol. 2018 Oct 14. doi: 10.1111/aos.13935.
    PubMed     Abstract available


  57. HAFNER J, Karst S, Sacu S, Scholda C, et al
    Correlation between corneal and retinal neurodegenerative changes and their association with microvascular perfusion in type II diabetes.
    Acta Ophthalmol. 2018 Oct 11. doi: 10.1111/aos.13938.
    PubMed     Abstract available


  58. GRAUSLUND J, Andersen N, Andresen J, Flesner P, et al
    Evidence-based Danish guidelines for screening of diabetic retinopathy.
    Acta Ophthalmol. 2018 Oct 11. doi: 10.1111/aos.13936.
    PubMed     Abstract available


  59. POSCH-PERTL L, Michelitsch M, Schwetz V, Gasser-Steiner V, et al
    Change in choroidal volume after dexamethasone intravitreal implant in eyes with diabetic macular oedema.
    Acta Ophthalmol. 2018 Oct 3. doi: 10.1111/aos.13905.
    PubMed    


    September 2018
  60. SCHRODER K, Szendroedi J, Benthin A, Gontscharuk V, et al
    German Diabetes Study - Baseline data of retinal layer thickness measured by SD-OCT in early diabetes mellitus.
    Acta Ophthalmol. 2018 Sep 21. doi: 10.1111/aos.13851.
    PubMed     Abstract available


  61. JOHANNESEN SK, Viken JN, Vergmann AS, Grauslund J, et al
    Optical coherence tomography angiography and microvascular changes in diabetic retinopathy: a systematic review.
    Acta Ophthalmol. 2018 Sep 20. doi: 10.1111/aos.13859.
    PubMed     Abstract available


  62. MENG W, Shah KP, Pollack S, Toppila I, et al
    A genome-wide association study suggests new evidence for an association of the NADPH Oxidase 4 (NOX4) gene with severe diabetic retinopathy in type 2 diabetes.
    Acta Ophthalmol. 2018 Sep 4. doi: 10.1111/aos.13769.
    PubMed     Abstract available


    August 2018
  63. SCHREUR V, van Asten F, Ng H, Weeda J, et al
    Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus.
    Acta Ophthalmol. 2018;96:459-464.
    PubMed     Abstract available


    June 2018
  64. RIM TH, Lee SY, Bae HW, Seong GJ, et al
    Increased risk of open-angle glaucoma among patients with diabetes mellitus: a 10-year follow-up nationwide cohort study.
    Acta Ophthalmol. 2018 Jun 4. doi: 10.1111/aos.13805.
    PubMed     Abstract available


  65. REZKALLAH A, Malcles A, Dot C, Voirin N, et al
    Evaluation of efficacy and safety of dexamethasone intravitreal implants before and after vitrectomy in a real-life study.
    Acta Ophthalmol. 2018;96:e544-e546.
    PubMed    


    April 2018
  66. STEFANICKOVA J, Cunha-Vaz J, Ulbig M, Pearce I, et al
    A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS).
    Acta Ophthalmol. 2018 Apr 25. doi: 10.1111/aos.13771.
    PubMed     Abstract available


  67. JAKOBSEN NS, Larsen DA, Bek T
    The area of fixation covaries with short-term changes in visual acuity after anti-vascular endothelial growth factor treatment in patients with diabetic macular oedema.
    Acta Ophthalmol. 2018 Apr 24. doi: 10.1111/aos.13773.
    PubMed     Abstract available


  68. BROADGATE S, Kiire C, Halford S, Chong V, et al
    Diabetic macular oedema: under-represented in the genetic analysis of diabetic retinopathy.
    Acta Ophthalmol. 2018;96 Suppl A111:1-51.
    PubMed     Abstract available


    March 2018
  69. DE MELO LGN, Morales PH, Drummond KRG, Santos DC, et al
    Prevalence and risk factors for referable diabetic retinopathy in patients with type 1 diabetes: a nationwide study in Brazil.
    Acta Ophthalmol. 2018 Mar 14. doi: 10.1111/aos.13760.
    PubMed    


  70. PEMP B, Palkovits S, Howorka K, Pumprla J, et al
    Correlation of retinal neurodegeneration with measures of peripheral autonomic neuropathy in type 1 diabetes.
    Acta Ophthalmol. 2018 Mar 5. doi: 10.1111/aos.13733.
    PubMed     Abstract available


    February 2018
  71. LIU TT, Hao Q, Zhang Y, Li ZH, et al
    Effects of microRNA-133b on retinal vascular endothelial cell proliferation and apoptosis through angiotensinogen-mediated angiotensin II- extracellular signal-regulated kinase 1/2 signalling pathway in rats with diabetic retinopathy.
    Acta Ophthalmol. 2018 Feb 28. doi: 10.1111/aos.13715.
    PubMed     Abstract available


    January 2018
  72. JANSSON RW, Hufthammer KO, Krohn J
    Diabetic retinopathy in type 1 diabetes patients in Western Norway.
    Acta Ophthalmol. 2018 Jan 25. doi: 10.1111/aos.13654.
    PubMed     Abstract available


    December 2017
  73. HODZIC-HADZIBEGOVIC D, Sander BA, Monberg TJ, Larsen M, et al
    Diabetic macular oedema treated with intravitreal anti-vascular endothelial growth factor - 2-4 years follow-up of visual acuity and retinal thickness in 566 patients following Danish national guidelines.
    Acta Ophthalmol. 2017 Dec 14. doi: 10.1111/aos.13638.
    PubMed     Abstract available


  74. FOGLIA E, Ferrario L, Bandello F, Ferri C, et al
    Diabetic macular edema, innovative technologies and economic impact: New opportunities for the Lombardy Region healthcare system?
    Acta Ophthalmol. 2017 Dec 14. doi: 10.1111/aos.13620.
    PubMed     Abstract available


  75. POSCH-PERTL L, Schwetz V, Michelitsch M, Rabensteiner J, et al
    Effect of dexamethasone intravitreal implant on blood glucose, hypothalamic-pituitary-adrenal axis function and vascular endothelial growth factor serum levels in patients with diabetic macular oedema.
    Acta Ophthalmol. 2017 Dec 8. doi: 10.1111/aos.13615.
    PubMed    


  76. GRAUSLUND J
    Vascular endothelial growth factor inhibition for proliferative diabetic retinopathy: Et tu, Brute?
    Acta Ophthalmol. 2017;95:757-758.
    PubMed    


    November 2017
  77. TORP TL, Kawasaki R, Wong TY, Peto T, et al
    Temporal changes in retinal vascular parameters associated with successful panretinal photocoagulation in proliferative diabetic retinopathy: A prospective clinical interventional study.
    Acta Ophthalmol. 2017 Nov 29. doi: 10.1111/aos.13617.
    PubMed     Abstract available


  78. VAN DER HEIJDEN AA, Abramoff MD, Verbraak F, van Hecke MV, et al
    Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System.
    Acta Ophthalmol. 2017 Nov 27. doi: 10.1111/aos.13613.
    PubMed     Abstract available


  79. CHEN C, Chen X, Huang H, Han C, et al
    Elevated plasma and vitreous levels of leucine-rich-alpha2-glycoprotein are associated with diabetic retinopathy progression.
    Acta Ophthalmol. 2017 Nov 23. doi: 10.1111/aos.13633.
    PubMed     Abstract available


  80. ABU EL-ASRAR AM, Ahmad A, Alam K, Bittoun E, et al
    Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy.
    Acta Ophthalmol. 2017 Nov 2. doi: 10.1111/aos.13600.
    PubMed     Abstract available


  81. DE CLERCK EEB, Schouten JSAG, Berendschot TTJM, Goezinne F, et al
    Macular thinning in prediabetes or type 2 diabetes without diabetic retinopathy: the Maastricht Study.
    Acta Ophthalmol. 2017 Nov 1. doi: 10.1111/aos.13570.
    PubMed     Abstract available


  82. LANG GE, Liakopoulos S, Vogeler J, Weiss C, et al
    The RELATION study: efficacy and safety of ranibizumab combined with laser photocoagulation treatment versus laser monotherapy in NPDR and PDR patients with diabetic macular oedema.
    Acta Ophthalmol. 2017 Nov 1. doi: 10.1111/aos.13574.
    PubMed     Abstract available


    October 2017
  83. PRAGER SG, Lammer J, Mitsch C, Hafner J, et al
    Analysis of retinal layer thickness in diabetic macular oedema treated with ranibizumab or triamcinolone.
    Acta Ophthalmol. 2017 Oct 24. doi: 10.1111/aos.13520.
    PubMed     Abstract available


    September 2017
  84. WANG K, Jayadev C, Nittala MG, Velaga SB, et al
    Automated detection of diabetic retinopathy lesions on ultrawidefield pseudocolour images.
    Acta Ophthalmol. 2017 Sep 19. doi: 10.1111/aos.13528.
    PubMed     Abstract available


  85. SCARINCI F, Picconi F, Giorno P, Boccassini B, et al
    Deep capillary plexus impairment in patients with type 1 diabetes mellitus with no signs of diabetic retinopathy revealed using optical coherence tomography angiography.
    Acta Ophthalmol. 2017 Sep 9. doi: 10.1111/aos.13510.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: